文献速递糖尿病肥胖与代谢综合征

减重手术对肥胖及2型糖尿病患者内皮与糖萼生物标志物的影响

Influence of Bariatric Surgery on Endothelial and Glycocalyx Biomarkers in Obesity and Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

在瑞典斯德哥尔摩单中心开展的前瞻性队列研究,纳入接受Roux-en-Y胃旁路术的成人,28例伴2型糖尿病、33例不伴2型糖尿病,随访2年。术前2周低热量饮食后E-Selectin、syndecan-1和VWF下降;术后2年E-Selectin、syndecan-1和VWF降低而透明质酸升高,TM不变。结论认为减重手术与糖萼及内皮功能生物标志物的持续有益改变相关。

要点

  • 基线时伴2型糖尿病者E-Selectin浓度更高(P = .041),其余标志物组间无差异。
  • 术后2年E-Selectin、syndecan-1和VWF降低,透明质酸升高,TM不变(P < .001)。
  • 体重和脂肪量下降及胰岛素敏感性改善对生物标志物改善预测价值最高。

核心结论

  • 减重手术与肥胖患者(无论是否伴2型糖尿病)糖萼和内皮功能生物标志物的持续有益改变相关。
  • 作者认为体重/脂肪量下降和胰岛素敏感性改善对这些改变尤为重要。

研究设计与样本

  • 前瞻性队列研究,在瑞典斯德哥尔摩单中心开展,随访2年。
  • 纳入接受减重手术的成人,28例伴2型糖尿病、33例不伴2型糖尿病。
  • 干预为Roux-en-Y胃旁路术,术前进行2周低热量饮食。

主要发现

  • 基线时伴2型糖尿病者E-Selectin浓度更高(P = .041),其他生物标志物组间无差异。
  • 低热量饮食后E-Selectin、syndecan-1和VWF降低。
  • 术后2年TM不变,E-Selectin几何均值(CV%)从41(40)降至24(61)ng/mL,syndecan-1从50(73)降至38(81)ng/mL,VWF从120(52)降至103(45)%,透明质酸从25(96)升至40(78)ng/mL(所有P < .001)。
  • E-Selectin在伴2型糖尿病患者中初期下降更快(P < .003),其余生物标志物变化组间无差异。
  • 对生物标志物改善预测价值最高的变量为体重和脂肪量下降及胰岛素敏感性(HOMA-IR)改善。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Bariatric surgery is associated with reduced risk of cardiometabolic disease in obesity and type 2 diabetes (T2D). The mechanisms are not fully understood, but improvement in endothelial dysfunction has been implicated. OBJECTIVE: This work aimed to assess endothelial biomarkers before and after surgery. METHODS: A prospective cohort study with 2-year follow-up was conducted at a single center in Stockholm, Sweden. Participants included adults undergoing bariatric surgery, 28 with and 33 without T2D. Intervention included Roux-en-Y gastric bypass preceded by a 2-week low-calorie diet (LCD). Main outcome measures included plasma concentrations of glycocalyx biomarkers (hyaluronan [HA] and syndecan-1), E-Selectin, von Willebrand factor (VWF), and thrombomodulin (TM). RESULTS: At baseline, patients with diabetes had higher concentrations of E-Selectin (P = .041) whereas other biomarkers did not differ between groups. After LCD, E-Selectin, syndecan-1, and VWF were reduced. Two years after surgery, TM was unchanged whereas E-Selectin decreased, geometric mean (CV%) 41 (40) to 24 (61) ng/mL, syndecan-1 from 50 (73) to 38 (81) ng/mL, and VWF from 120 (52) to 103 (45)%, while HA increased from 25 (96) to 40 (78) ng/mL (P < .001 for all). E-Selectin initially declined faster in patients with diabetes (P < .003); otherwise the biomarker changes did not differ between groups. Variables with the highest predictive value for improvement in biomarkers were decrease in body weight and fat mass and increase in insulin sensitivity (HOMA-IR). CONCLUSION: Bariatric surgery is associated with sustained, beneficial alterations in biomarkers of glycocalyx and endothelial function in patients with obesity, both with and without T2D. It is suggested that reduced body weight/fat mass and improved insulin sensitivity are of particular importance for these alterations.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Andersson M, Ågren A, Henriksson P, et al. Influence of Bariatric Surgery on Endothelial and Glycocalyx Biomarkers in Obesity and Type 2 Diabetes. J Clin Endocrinol Metab. 2025. PMID: 39943818. doi:10.1210/clinem/dgaf092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。